 |
PDBsum entry 2j88
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
319 a.a.
|
 |
|
|
|
|
|
|
|
162 a.a.
|
 |
|
|
|
|
|
|
|
175 a.a.
|
 |
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Identification of a b-Cell epitope of hyaluronidase, A major bee venom allergen, From its crystal structure in complex with a specific FAB.
|
 |
|
Authors
|
 |
S.Padavattan,
T.Schirmer,
M.Schmidt,
C.Akdis,
R.Valenta,
I.Mittermann,
L.Soldatova,
J.Slater,
U.Mueller,
Z.Markovic-Housley.
|
 |
|
Ref.
|
 |
J Mol Biol, 2007,
368,
742-752.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
|
Note In the PDB file this reference is
annotated as "TO BE PUBLISHED".
The citation details given above were identified by an automated
search of PubMed on title and author
names, giving a
perfect match.
|
 |
 |
|
Abstract
|
 |
|
The major allergens of honeybee venom, hyaluronidase (Hyal) and phospholipase
A2, can induce life-threatening IgE-mediated allergic reactions in humans.
Although conventional immunotherapy is effective, up to 40% of patients develop
allergic side effects including anaphylaxis and thus, there is a need for an
improved immunotherapy. A murine monoclonal anti-Hyal IgG1 antibody (mAb 21E11),
that competed for Hyal binding with IgEs from sera of bee venom allergic
patients, was raised. The fragment of these IgG antibodies which bind to antigen
(Fab) was produced and complexed (1:1) with Hyal. The crystal structure
determination of Hyal/Fab 21E11 complex (2.6 A) enabled the identification of
the Hyal-IgG interface which provides indirect information on the Hyal-IgE
interaction (B-cell epitope). The epitope is composed of a linear array of nine
residues (Arg138, His141-Arg148) located at the tip of a helix-turn-helix motive
which protrudes away from the globular core and fits tightly into the deep
surface pocket formed by the residues from the six complementarity determining
regions (CDRs) of the Fab. The epitope is continuous and yet its conformation
appears to be essential for Ab recognition, since the synthetic 15-mer peptide
comprising the entire epitope (Arg138-Glu152) is neither recognized by mAb 21E11
nor by human IgEs. The structure of the complex provides the basis for the
rational design of Hyal derivatives with reduced allergenic activity, which
could be used in the development of safer allergen-specific immunotherapy.
|
 |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1. Close-up stereo view of the final SigmaA-weighted
2F[o]–F[c] electron density map^60 contoured at 1.0σ. Shown
is part of the Hyal/Fab interface with Hyal and Fab heavy chain
colored magenta and yellow, respectively. All pictures were
produced using program DINO [http://www.dino3d.org/].
|
 |
Figure 3.
Figure 3. Stereo view of the polar and ionic interactions
within the Hyal/Fab complex. Same color code as in Figure 1 and
Figure 2. Hydrogen bonds (magenta) and salt bridges (cyan) are
shown as dashed lines. Water-mediated interaction is shown in
blue. For clarity, residue Arg138 of Hyal is not shown. For more
details, see Table 4 and Table 5.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2007,
368,
742-752)
copyright 2007.
|
 |
|
|
|
|
 |